The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1639
ISSUE1639
December 13, 2021
Varenicline Nasal Spray (Tyrvaya) for Dry Eye Disease
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Varenicline Nasal Spray (Tyrvaya) for Dry Eye Disease
December 13, 2021 (Issue: 1639)
Tyrvaya (Oyster Point), a nasal spray formulation
of the cholinergic agonist varenicline, has been
approved by the FDA for treatment of dry eye disease.
It is the first nasal spray to be approved in the US
for this indication. An oral formulation...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.